Cardiol Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cardiol Therapeutics (CRDL).

Price Target Range — 8 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$10Upside to Avg. PT+822.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 23, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$9
Aug 17, 2026	Canaccord Genuity	Edward Nash	PT Raise	Buy	$8→$10
Jul 14, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$9
Apr 6, 2026	Canaccord Genuity	Edward Nash	Maintained	Buy	$8
Feb 10, 2026	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$9
Dec 1, 2025	HC Wainwright & Co.	Brandon Folkes	Maintained	Buy	$9
Jun 2, 2025	HC Wainwright & Co.	Brandon Folkes	Initiate	Buy	$9
Apr 16, 2025	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Apr 7, 2025	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Feb 24, 2025	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Dec 18, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Nov 20, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Oct 24, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Jun 26, 2024	Roth MKM	Jason Wittes	Initiate	Buy	$10
Jun 14, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Jun 7, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
May 23, 2024	Canaccord Genuity	Edward Nash	PT Raise	Buy	$6→$8
May 14, 2024	HC Wainwright & Co.	Vernon Bernardino	Maintained	Buy	$9
Apr 22, 2024	HC Wainwright & Co.	Vernon Bernardino	Initiate	Buy	$9

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
Canaccord Genuity Maintains Buy on Cardiol Therapeutics, Raises Price Target to $10

Canaccord Genuity analyst Edward Nash maintains Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and raises the price target from $8 to $10.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

HC Wainwright & Co. analyst Brandon Folkes reiterates Cardiol Therapeutics (NASDAQ:CRDL) with a Buy and maintains $9 price target.

Benzinga Newsdesk

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

Cardiol Therapeutics Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Cardiol Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PRO
Canaccord Genuity Maintains Buy on Cardiol Therapeutics, Raises Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

People Also Watch

People Also Watch

Cardiol Therapeutics Inc

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

Cardiol Therapeutics Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PROCanaccord Genuity Maintains Buy on Cardiol Therapeutics, Raises Price Target to $10

PROHC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PROHC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PROHC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PRO
Canaccord Genuity Maintains Buy on Cardiol Therapeutics, Raises Price Target to $10

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target